Healthcare Venture Capital Revenue and Competitors
Estimated Revenue & Valuation
- Healthcare Venture Capital's estimated annual revenue is currently $1.7M per year.
- Healthcare Venture Capital's estimated revenue per employee is $51,515
Employee Data
- Healthcare Venture Capital has 33 Employees.
- Healthcare Venture Capital grew their employee count by -17% last year.
Healthcare Venture Capital's People
Name | Title | Email/Phone |
---|
Healthcare Venture Capital Competitors & AlternativesAdd Company
Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
---|---|---|---|---|---|
#1 | $7.5M | 22 | 5% | $78.9M | N/A |
#2 | $35M | 16 | N/A | N/A | N/A |
#3 | $3.5M | 12 | 0% | N/A | N/A |
#4 | N/A | 36 | -3% | N/A | N/A |
#5 | $3.5M | 43 | 0% | N/A | N/A |
#6 | $7.5M | 10 | -55% | N/A | N/A |
#7 | N/A | 35 | -3% | N/A | N/A |
#8 | N/A | 10 | -9% | N/A | N/A |
#9 | $7.5M | 8 | -27% | N/A | N/A |
#10 | $1.7M | 56 | 0% | N/A | N/A |
What Is Healthcare Venture Capital?
Holding company.
keywords:N/AN/A
Total Funding
33
Number of Employees
$1.7M
Revenue (est)
-17%
Employee Growth %
N/A
Valuation
N/A
Accelerator
Healthcare Venture Capital News
2022-04-17 - Biotech venture capital: Top 10 money-raisers of 2021
Abogen Biosciences · ElevateBio · EQRx · Neumora · Laronde Therapeutics · Adagio Therapeutics · Sotio Biotech · Altos Labs.
2022-04-06 - AmerisourceBergen launches $150 million venture capital fund for ...
The wholesale giant's new VC fund, called AB Health Ventures, will initially look to invest in early to midstage health-related startups both in the U.S. and...
2022-04-06 - InnovationRx: Venture Capital For Digital Health Is Down; Plus, The ...
D igital health venture funding hit $6 billion across 183 deals in the first quarter of 2022 with an average deal size of $32.8 million,...
Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
---|---|---|---|---|
#1 | $3.2M | 33 | 74% | N/A |
#2 | $5.4M | 33 | -11% | N/A |
#3 | $6.8M | 33 | -8% | N/A |
#4 | $6.2M | 34 | 3% | N/A |
#5 | $5.7M | 34 | -26% | N/A |